These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16311626)

  • 21. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    Setiawan VW; Schumacher FR; Haiman CA; Stram DO; Albanes D; Altshuler D; Berglund G; Buring J; Calle EE; Clavel-Chapelon F; Cox DG; Gaziano JM; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn J; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Ma J; Le Marchand L; Linseisen J; Lund E; Navarro C; Overvad K; Palli D; Peeters PH; Pike MC; Riboli E; Stampfer MJ; Thun MJ; Travis R; Trichopoulos D; Yeager M; Ziegler RG; Spencer Feigelson H; Chanock SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2237-46. PubMed ID: 18006912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
    Haiman CA; Han Y; Feng Y; Xia L; Hsu C; Sheng X; Pooler LC; Patel Y; Kolonel LN; Carter E; Park K; Le Marchand L; Van Den Berg D; Henderson BE; Stram DO
    PLoS Genet; 2013 Mar; 9(3):e1003419. PubMed ID: 23555315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
    Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS
    Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.
    Obazee O; Justenhoven C; Winter S; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Hannelius U; Li J; Humphreys K; Hall P; Giles G; Severi G; Baglietto L; Southey M; Rabstein S; Harth V; Lotz A; Pesch B; Brüning T; Baisch C; Ko YD; Hamann U; Brauch H
    Breast Cancer Res Treat; 2013 Apr; 138(2):543-8. PubMed ID: 23430226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
    Tang L; Platek ME; Yao S; Till C; Goodman PJ; Tangen CM; Wu Y; Platz EA; Neuhouser ML; Stanczyk FZ; Reichardt JKV; Santella RM; Hsing A; Figg WD; Lippman SM; Thompson IM; Ambrosone CB
    Carcinogenesis; 2018 Feb; 39(2):125-133. PubMed ID: 29228205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
    Holt SK; Karyadi DM; Kwon EM; Stanford JL; Nelson PS; Ostrander EA
    Clin Cancer Res; 2008 Jun; 14(12):3823-31. PubMed ID: 18559602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
    Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19.
    Tsuchiya M; Nakao H; Katoh T; Sasaki H; Hiroshima M; Tanaka T; Matsunaga T; Hanaoka T; Tsugane S; Ikenoue T
    Hum Reprod; 2005 Apr; 20(4):974-8. PubMed ID: 15640252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.
    Lutkowska A; Roszak A; Jagodziński PP
    Pathol Oncol Res; 2017 Apr; 23(2):317-322. PubMed ID: 27571989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.
    Feigelson HS; McKean-Cowdin R; Coetzee GA; Stram DO; Kolonel LN; Henderson BE
    Cancer Res; 2001 Jan; 61(2):785-9. PubMed ID: 11212283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.
    Sun T; Oh WK; Jacobus S; Regan M; Pomerantz M; Freedman ML; Lee GS; Kantoff PW
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2044-50. PubMed ID: 21900597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study.
    Stram DO; Haiman CA; Hirschhorn JN; Altshuler D; Kolonel LN; Henderson BE; Pike MC
    Hum Hered; 2003; 55(1):27-36. PubMed ID: 12890923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-nucleotide polymorphisms in the 17beta-hydroxysteroid dehydrogenase genes might predict the risk of side-effects of estramustine phosphate sodium in prostate cancer patients.
    Suzuki M; Muto S; Hara K; Ozeki T; Yamada Y; Kadowaki T; Tomita K; Kameyama S; Kitamura T
    Int J Urol; 2005 Feb; 12(2):166-72. PubMed ID: 15733111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
    Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
    Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.
    Loukola A; Chadha M; Penn SG; Rank D; Conti DV; Thompson D; Cicek M; Love B; Bivolarevic V; Yang Q; Jiang Y; Hanzel DK; Dains K; Paris PL; Casey G; Witte JS
    Eur J Hum Genet; 2004 Apr; 12(4):321-32. PubMed ID: 14560315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of 17β-hydroxysteroid dehydrogenase type gene 1 937 A>G polymorphism in infertility in Polish Caucasian women with endometriosis.
    Osiński M; Mostowska A; Wirstlein P; Skrzypczak J; Jagodziński PP; Szczepańska M
    J Assist Reprod Genet; 2017 Jun; 34(6):789-794. PubMed ID: 28405865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haplotypes of the estrogen receptor beta gene and breast cancer risk.
    ; Cox DG; Bretsky P; Kraft P; Pharoah P; Albanes D; Altshuler D; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Calle EE; Canzian F; Chanock S; Clavel-Chapelon F; Colditz GA; Feigelson HS; Haiman CA; Hankinson SE; Hirschhorn J; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; LeMarchand L; Lund E; Palli D; Peeters PH; Pike MC; Riboli E; Stram DO; Thun M; Tjonneland A; Travis RC; Trichopoulos D; Yeager M
    Int J Cancer; 2008 Jan; 122(2):387-92. PubMed ID: 17935138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
    Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
    Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
    Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.